Position in BTAI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,559,501
New position
Shares Held
1,910,076
first reported quarter
Ownership
6.19%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2
of 40 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ARMISTICE CAPITAL, LLC holds $281,938,279 across 8 Drug Manufacturers - Specialty & Generic names. BTAI ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,895,347 | $97,970,486 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
724,000 | $95,379,760 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
15,028,000 | $52,748,280 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,909,838 | $11,077,060 | |
| 5 | ESPR |
Esperion Therapeutics, Inc.
|
3,930,125 | $10,768,542 | |
| 6 | EOLS |
Evolus, Inc.
|
1,396,000 | $5,737,560 | |
| 7 | CTOR |
Citius Oncology, Inc.
|
9,188,855 | $5,697,090 | |
| 8 | BTAI |
BioXcel Therapeutics, Inc.
This page
|
1,910,076 | $2,559,501 |
All Filings in BTAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,559,501 | 1,910,076 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||